235
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Development, in vitro Evaluation, and in vivo Study of Adhesive Buccal Films for the Treatment of Diabetic Pediatrics via Trans Mucosal Delivery of Gliclazide

, , , , , , & show all
Pages 4235-4250 | Received 31 Oct 2022, Accepted 02 Dec 2022, Published online: 05 Dec 2023

References

  • Wahyuni Y. Improving the quality of life of patients with diabetes mellitus type 2 with treatment adherence. Media Keperawatan Indonesia. 2021;4(3):244. doi:10.26714/mki.4.3.2021.244-256
  • Verma S, Gupta M, Popli H, Aggarwal G. Diabetes mellitus treatment using herbal drugs. Int J Phytomed. 2018;10(1):1. doi:10.5138/09750185.2181
  • Gaber DA, Alhuwaymili AS, Alhawas HS. Synthesized nano particles of glimepiride via spray freezing into cryogenic liquid: characterization, antidiabetic activity, and bioavailability. Drug Deliv. 2022;29:364–373. doi:10.1080/10717544.2021.2018524
  • Singh A, Singh R. Is gliclazide a sulfonylurea with difference? A review in 2016. Expert Rev Clin Pharmacol. 2016;9(6):839–851. doi:10.1586/17512433.2016.1159512
  • Singh R, Ahmed A, Bhattacharya K. Pharmacoscintigraphic evaluation and antidiabetic efficacy of gliclazide-loaded 99mTc-labelled mucoadhesive microspheres. Future J Pharma Sci. 2021;7(1). doi:10.1186/s43094-021-00322-3
  • Sarkar A, Tiwari A, Bhasin PS, Mitra M. Pharmacological and pharmaceutical profile of gliclazide: a review. J Appl Pharm Sci. 2011;1(9):11–19.
  • Alkhamis KA, Allaboun H, Al-Momani WY. Study of the solubilization of gliclazide by aqueous micellar solutions. J Pharm Sci. 2003;92:839–846. doi:10.1002/jps.10350
  • Varshosaz J, Talari R, Mostafavi SA, Nokhodchi A. Dissolution enhancement of gliclazide using in situ micronization by solvent change method. Powder Technol. 2008;187:222–230. doi:10.1016/j.powtec.2008.02.018
  • Saharan VA, Choudhury PK. Dissolution rate enhancement of gliclazide by ordered mixing. Acta Pharm. 2011;61:323–334. doi:10.2478/v10007-011-0021-7
  • Hosmani AH, Thorat YS. Optimization and pharmacodynamic evaluation of solid dispersion of gliclazide for dissolution rate enhancement. Lat Am J Pharm. 2011;30:1590–1595.
  • Ahmady A, Samah NH. A review: gelatine as a bioadhesive material for medical and pharmaceutical applications. Int J Pharm. 2021;608:121037. doi:10.1016/j.ijpharm.2021.121037
  • Padhi S, Nayak A, Behera A. Type II diabetes mellitus: a review on recent drug based therapeutics. Biomed Pharmacother. 2020;131:110708. doi:10.1016/j.biopha.2020.110708
  • Jacob S, Nair AB, Boddu SH, Gorain B, Sreeharsha N, Shah J. An updated overview of the emerging role of patch and film-based buccal delivery systems. Pharmaceutics. 2021;13(8):1206. doi:10.3390/pharmaceutics13081206
  • Singh R, Sharma D, Garg R. Review on mucoadhesive drug delivery system with special emphasis on buccal route: an important tool in designing of novel controlled drug delivery system for the effective delivery of pharmaceuticals. J Dev Drugs. 2017;6(01):1–2.
  • Aframian D, Davidowitz T, Benoliel R. The distribution of oral mucosal pH values in healthy saliva secretors. Oral Dis. 2006;12(4):420–423. doi:10.1111/j.1601-0825.2005.01217.x
  • Bala R, Khanna S, Pawar P, Arora S. Orally dissolving strips: a new approach to oral drug delivery system. Int J Pharm Investig. 2013;3(2):67. doi:10.4103/2230-973X.114897
  • Gilhotra RM, Ikram M, Srivastava S, Gilhotra N. A clinical perspective on mucoadhesive buccal drug delivery systems. J Biomed Res. 2014;28(2):81–97. doi:10.7555/JBR.27.20120136
  • Boddupalli B, Mohammed Z, Nath R, Banji D. Mucoadhesive drug delivery system: an overview. J Adv Pharm Technol Res. 2010;1(4):381. doi:10.4103/0110-5558.76436
  • Shaikh R, Singh TR, Garland MJ, Woolfson AD, Donnelly RF. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci. 2011;3(1):89. doi:10.4103/0975-7406.76478
  • Jovanović M, Tomić N, Cvijić S, Stojanović D, Ibrić S, Uskoković P. Mucoadhesive gelatin buccal films with propranolol hydrochloride: evaluation of mechanical, mucoadhesive, and biopharmaceutical properties. Pharmaceutics. 2021;13(2):273. doi:10.3390/pharmaceutics13020273
  • Falath W, Sabir A, Jacob KI. Novel reverse osmosis membranes composed of modified PVA/Gum Arabic conjugates: biofouling mitigation and chlorine resistance enhancement. Carbohydr Polym. 2017;155:28–39. doi:10.1016/j.carbpol.2016.08.058
  • Irikura K, Ekapakul N, Choochottiros C, Chanthaset N, Yoshida H, Ajiro H. Fabrication of flexible blend films using a chitosan derivative and poly (trimethylene carbonate). Polymer J. 2021;53(7):823–833. doi:10.1038/s41428-021-00470-6
  • Priyanka R, Prabhu R. Carbopol 71G-NF polymer –the next pillar of oral solid dosage form. Magna Scientia Adv Res Rev. 2020;1:010–017. doi:10.30574/msarr.2020.1.1.0018
  • Kamel S, Ali N, Jahangir K, Shah S, El-Gendy A. Pharmaceutical significance of cellulose: a review. J Express Polym Lett. 2008;2:758–778. doi:10.3144/expresspolymlett.2008.90
  • Martin Pastor M, Stoyanov E. Mechanism of interaction between hydroxypropyl cellulose and water in aqueous solutions: importance of polymer chain length. J Polymer Sci. 2020;58(12):1632–1641. doi:10.1002/pol.20200185
  • Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci. 2012;37(1):106–126. doi:10.1016/j.progpolymsci.2011.06.003
  • Krishnan V, Sasikumar S, Dass F, Vijayaraghavan R. Effect of Pore forming agents on the physical characteristics and release kinetics of levofloxacin hemihydrate from floating alginate drug delivery system - an in vitro study. J Trends Biomater Artif Organs. 2010;24:139–145.
  • Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev. 2005;57:1666–1691. doi:10.1016/j.addr.2005.07.003
  • Marin EL, Modamio P. Transdermal absorption of celiprolol and bisoprolol in human skin in vitro. Int J Pharma. 1998;173:141–148.
  • Mohamad SA, Salem H, Yassin HA, Mansour HF. Bucco-adhesive film as a pediatric proper dosage form for systemic delivery of propranolol hydrochloride: in-vitro and in-vivo evaluation. Drug Des Devel Ther. 2020;14:4277. doi:10.2147/DDDT.S267317
  • Pedacchia A, Adrover A. Study of release kinetics and diffusion coefficients in swellable cellulosic thin films by means of a simple spectrophotometric technique. Chem Eng Res Des. 2014;92(11):2550–2556. doi:10.1016/j.cherd.2014.03.017
  • Ganji F, Vasheghani FS, Vasheghani FE. Theoretical description of hydrogel swelling: a review. Iran Polym J. 2010;19(5):375–398.45.
  • Semalty A, Semalty M, Nautiyal U. Formulation and evaluation of mucoadhesive buccal films of enalapril maleate. Indian J Pharm Sci. 2010;72(5):571–575. doi:10.4103/0250-474X.78522
  • Gupta A, Garg S, Khar RK. Measurement of bioadhesive strength of muco-adhesive buccal tablets: design of an in-vitro assembly. Indian Drugs. 1992;30:152–155.
  • Kumria R, Nair AB, Goomber G, Gupta S. Buccal films of prednisolone with enhanced bioavailability. Drug Deliv. 2016;23(2):471–478. doi:10.3109/10717544.2014.920058
  • Gaber D, Abdoun S, Alfuraihy A, Altasan B, Alsubaiyel A. Superhydrophobic surface for enhancing the bioavailability of salbutamol sulfate from cross-linked microspheres: formulation, characterization, and in vivo evaluation. Drug Des Devel Ther. 2021;15:2869–2884. doi:10.2147/DDDT.S309078
  • Binhashim NH, Alvi SN, Hammami MM. A validated reversed phase HPLC assay for the determination of gliclazide in human plasma. Saudi J Med Pharm Sci. 2022;10B:1128–1132.
  • Sapkal NP, Kilor VA, Bhusari KP, Daud AS. Evaluation of some methods for preparation of gliclazide- β-cyclodextrin inclusion complexes. Trop J Pharm Res. 2007;6(4):833–840. doi:10.4314/tjpr.v6i4.14667
  • Stetinova V, Polaskova A, Smetanova L, Kholova D, Herout V, Kvetina J. Toxicological studies, membrane transport and pharmacodynamic effect of gliclazide in rats. Toxicol Lett. 2008;180:58–59. doi:10.1016/j.toxlet.2008.06.639
  • Mapa B, Araújo L, Silva-Barcellos N, Caldeira T, Souza J. Gliclazide: biopharmaceutics characteristics to discuss the biowaiver of immediate and extended release tablets. Appl Sci. 2020;10(20):7131. doi:10.3390/app10207131
  • Li L, Li J, Si S. Effect of formulation variables on in vitrorelease of a water-soluble drug from chitosan-sodium alginate matrix tablets. Asian J Pharma Sci. 2015;10(4):314–321. doi:10.1016/j.ajps.2014.09.002
  • El Sharawy AM, Shukr MH, Elshafeey AH. Formulation and optimization of duloxetine hydrochloride buccal films: in vitro and in vivo evaluation. Drug Deliv. 2017;24(1):1762–1769. doi:10.1080/10717544.2017.1402216
  • Nair AB, Shah J, Jacob S, et al. Development of mucoadhesive buccal film for rizatriptan: in vitro and in vivo evaluation. Pharmaceutics. 2021;13(5):728. doi:10.3390/pharmaceutics13050728
  • Mady OY, Donia AM, Al-Madboly LA. Miconazole-urea in a buccal film as a new trend for treatment of resistant mouth fungal white patches. Front Microbiol. 2018;9:837. doi:10.3389/fmicb.2018.00837
  • Yildiz Pekoz A, Sedef Erdal M, Okyar A, et al. Preparation and in- vivo evaluation of dimenhydrinate buccal mucoadhesive films with enhanced bioavailability. Drug Dev Ind Pharm. 2016;42:916–925. doi:10.3109/03639045.2015.109147061
  • Koland M, Charyulu RN, Vijayanarayana K, Prabhu P. In vitro and in vivo evaluation of chitosan buccal films of ondansetron hydrochloride. Int J Pharm Investig. 2011;1:64–71. doi:10.4103/2230-973X.85967
  • Tejada G, Barrera M, Piccirilli G, et al. Development and evaluation of buccal films based on chitosan for the potential treatment of oral candidiasis. AAPS PharmSciTech. 2017;18(4):936–946. doi:10.1208/s12249-017-0720-652
  • Bahri-Najafi R, Tavakoli N, Senemar M, Peikanpour M. Preparation and pharmaceutical evaluation of glibenclamide slow release mucoadhesive buccal film. Res Pharm Sci. 2014;9(3):213–223.
  • Mohamad SA, Sarhan HA, Abdelkader H, Mansour HF. Vitamin B12-loaded buccoadhesive films as a noninvasive supplement in vitamin B12 deficiency: in vitro evaluation and in vivo comparative study with intramuscular injection. J Pharm Sci. 2017;106:1849–1858. doi:10.1016/j.xphs.2017.03.04025
  • Svensson O, Arnebrant T. Mucin layers and multilayers— physicochemical properties and applications. Curr Opin Colloid Interface Sci. 2010;15:395–405. doi:10.1016/j.cocis.2010.05.015
  • Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139:94–107. doi:10.1016/j.jconrel.2009.06.01411
  • Trastullo R, Abruzzo A, Saladini B, et al. Design and evaluation of buccal films as pediatric dosage form for trans mucosal delivery of ondansetron. Eur J Pharm Biopharm. 2016;105:115–121. doi:10.1016/j.ejpb.2016.05.026